2015 – ESSA Pharma

Date	Title
December 15, 2015	ESSA PHARMA ANNOUNCES FILING OF PRELIMINARY SHELF PROSPECTUS AND REGISTRATION STATEMENT
December 14, 2015	ESSA PHARMA INC. REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2015
November 24, 2015	ESSA Announces Enrollment of First Patient in Phase 1/2 Trial
November 5, 2015	ESSA Pharma Inc. Receives Health Canada Approval to Commence Clinical Development for EPI-506
September 23, 2015	ESSA Pharma Inc. Receives FDA Approval to Commence Clinical Development
August 17, 2015	ESSA PHARMA INC. REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS
July 28, 2015	ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange
July 2, 2015	ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market
June 24, 2015	ESSA Pharma Inc. Announces Appointment of New Director
May 28, 2015	ESSA PHARMA INC. REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS